Generic name |
aprepitant |
---|---|
Strength | 80 mg, 125 mg, Tri-Pack 125MG-80MG CAP DS PK |
Form |
capsule |
Special Authority criteria |
Approval period |
---|---|
For the prevention of acute and delayed nausea and vomiting due to highly-emetogenic cancer chemotherapy in combination with a 5-HT3 antagonist and dexamethasone. |
Up to a maximum number of standard, planned treatment cycles of highly-emetogenic cancer chemotherapy (usually 6 or fewer treatment cycles), as specified in the relevant BC Cancer Agency chemotherapy protocol. |